Epidemic dropsy
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
epidemic dropsy sanguinarine Argemone mexicana
Searching PubMed
epidemic dropsy sanguinarine
Finding Sources
Searching the Web
epidemic dropsy clinical features pathogenesis treatment sanguinarine Argemone mexicana
Reading Article
Reading Article
Searching Images
epidemic dropsy pitting edema erythema
Based on the retrieved literature, here is a comprehensive overview of Epidemic Dropsy:
Epidemic Dropsy
Definition
Epidemic dropsy is a clinical syndrome caused by consumption of edible oils (most commonly mustard oil) adulterated with oil extracted from seeds of the prickly poppy Argemone mexicana. It has occurred in epidemic form in India, Mauritius, Fiji Islands, and South Africa.
Aetiology & Pathogen
| Factor | Detail |
|---|---|
| Adulterant plant | Argemone mexicana (prickly poppy) |
| Route | Ingestion of contaminated cooking oil (mustard oil most commonly) |
| Toxic alkaloids | Sanguinarine and dehydrosanguinarine (benzophenanthridine alkaloids) |
Seeds of A. mexicana closely resemble mustard seeds and contaminate mustard crops. The oil extracted from them carries these potent toxins.
Pathophysiology
Sanguinarine and dehydrosanguinarine exert toxicity through several mechanisms:
- Capillary damage — Widespread capillary dilatation, proliferation, and increased capillary permeability → protein-rich plasma leaks into the extracellular compartment → oedema
- Relative hypovolaemia — Vascular dilatation leads to a state of relative intravascular volume depletion, stimulating renal salt and water retention
- Metabolic disruption — Inhibition of Na⁺/K⁺-ATPase in multiple organs (brain, heart, liver, intestine, skeletal muscle); uncoupling of oxidative phosphorylation → accumulation of pyruvate → breathlessness
- Hepatotoxicity — Impairment of cytochrome P-450 (Phase I & II enzymes); increased hepatic lipid peroxidation (microsomal and mitochondrial)
- DNA damage — Sanguinarine binds DNA templates; co-carcinogenic potential demonstrated in animal models
- Erythrocyte membrane damage — Sanguinarine stimulates sucrose-sensitive haemolysis and breakdown of membrane phospholipid asymmetry
Clinical Features
Illness typically unfolds in stages:
1. Gastrointestinal (early)
- Nausea, vomiting, diarrhoea
- Abdominal pain
2. Cutaneous
- Erythema of the skin
- Pigmentation / skin discolouration
3. Oedema (cardinal feature)
- Bilateral pitting oedema of legs/feet — the hallmark finding
- Can progress to generalised oedema
4. Cardiorespiratory
- Cough, shortness of breath, orthopnoea
- Right-sided congestive cardiac failure (cor pulmonale picture)
5. Ocular
- Retinal haemorrhages
- Glaucoma (epidemic dropsy glaucoma — a well-recognised complication)
6. Haematological / Biochemical
- Mild to moderate anaemia
- Hypoproteinaemia
- Mild to moderate renal azotaemia
- Elevated blood pyruvate levels
Diagnosis
Diagnosis is primarily clinical and epidemiological:
- Cluster of cases in a community
- History of mustard oil consumption from a common source
- Characteristic clinical picture (oedema + erythema + GI symptoms)
Laboratory confirmation: Detection of sanguinarine in the implicated oil (chemical analysis); elevated blood pyruvate
Treatment
There is no specific antidote. Management is symptomatic:
| Intervention | Rationale |
|---|---|
| Remove adulterated oil | Eliminates ongoing toxin exposure |
| Diuretics | Manage oedema and cardiac failure |
| Antioxidants (Vitamins C, E) | Counter oxidative stress and lipid peroxidation |
| Multivitamins | Correct nutritional deficiencies |
| Calcium- and protein-rich diet | Correct hypoproteinaemia |
| Management of cardiac failure | Standard heart failure therapy |
| Glaucoma treatment | Topical/systemic antiglaucoma agents |
| Steroids | Benefit suggested in some case series |
Prevention
- Selective cultivation of yellow mustard (morphologically distinct from Argemone, reducing contamination)
- Strict enforcement of food adulteration laws (e.g., Indian Food Adulteration Act)
- Chemical testing of mustard oil before sale
- Public education and surveillance
Epidemiology
Major outbreaks have occurred in:
- India — the most affected country; multiple large outbreaks including a major Delhi outbreak in 1998
- Mauritius, Fiji, South Africa
All ages and sexes are affected; most cases cluster within families or localities sharing a common oil source.
Key References (PubMed):
- Sharma BD et al. Epidemic dropsy in India. Postgrad Med J 1999 — PMID 10621875
- Das M & Khanna SK. Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil. Crit Rev Toxicol 1997 — PMID 9189656
This is a shared conversation. Sign in to Orris to start your own chat.